$AMGN 3 SEC Filings

Filed On	Filing
04 Sep 2026	Form 3: Dittrich Thomas J.w., EVP & CFO Holds 16,860 shares of Common Stock
04 Jun 2024	Form 3: Klotman Mary E., Director No securities owned
19 Dec 2023	Form 3: Bradner James E., EVP, R&D, & Chief Sci. Officer No securities owned
14 Sep 2023	Form 3: Amgen Inc, 10% owner · Neumora Therapeutics Inc
21 Aug 2023	Form 3: Busch Matthew C., VP, Finance & CAO Holds 4,596 shares of Common Stock
03 Aug 2022	Form 3: Drake Michael V, Director No securities owned
17 Mar 2022	Form 3: Miller Derek, SVP, Human Resources Holds 5,843 shares of Common Stock
06 Jan 2022	Form 3: Amgen Inc, 10% owner · Vigil Neuroscience, Inc.
13 Sep 2021	Form 3: Khosla Rachna, SVP, Business Development Holds 4,068 shares of Common Stock
30 Jul 2021	Form 3: Ishrak Omar, Director No securities owned
29 Jul 2020	Form 3: Louie Linda H., VP, Finance & CAO Holds 6,175 shares of Common Stock
27 Jul 2020	Form 3: Miles Amy E, Director No securities owned
01 Jul 2020	Form 3: Grygiel Nancy A., SVP & CCO Holds 3,142 shares of Common Stock
07 Jan 2020	Form 3: Griffith Peter H., EVP & CFO Holds 18,465 shares of Common Stock
02 Jan 2020	Form 3: Amgen Inc, 10% owner · BeOne Medicines AG Holds 206,635,013 shares of Ordinary Shares
11 Sep 2018	Form 3: Gordon Murdo, EVP Global Commercial Ops No securities owned
02 Aug 2018	Form 3: Reese David M, EVP, Research and Development Holds 17,732 shares of Common Stock
20 Jun 2018	Form 3: Onyx Therapeutics, Inc., 10% owner and 1 other · Kezar Life Sciences, Inc.
22 May 2018	Form 3: Druker Brian, Director Holds 0 shares of Common Stock
12 Dec 2017	Form 3: Austin Wanda M, Director No securities owned

Comments